XV Association for Ocular Pharmacology and Therapeutics Meeting (AOPT 2021)
第十五届眼部药理学和治疗协会会议(AOPT 2021)
基本信息
- 批准号:10515332
- 负责人:
- 金额:$ 2.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-12-01 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAgeAnteriorAnterior eyeball segment structureAwardBasic ScienceBig Data MethodsBiotechnologyBudgetsCaringClinicClinicalClinical ResearchCollaborationsCreativenessDevelopmentDevicesDiagnosisDisciplineDiseaseDrug Delivery SystemsDrug KineticsEnvironmentEthnic PopulationEyeEye DevelopmentEye diseasesFeedbackFellowshipFloridaFosteringFundingFutureGoalsGrantHealth ProfessionalIndividualIndustryInstitutionInternationalInterventionJournalsKnowledgeLeadershipLearningLogisticsMedicineMetabolismMindMissionNatural regenerationNatureOccupationsOralParticipantPeer ReviewPersonsPharmacologic SubstancePharmacologyPharmacy (field)Positioning AttributePosterior eyeball segment structurePrivate PracticePublicationsRegenerative MedicineRequest for ApplicationsResearchResearch PersonnelRestRetinaSafetyScheduleScientistSocietiesStretchingStudentsTechnologyTherapeuticTranslational ResearchTranslationsTravelUnderrepresented MinorityVisionVision researchWomancareereditorialethnic diversityinsightinterestlecturesmedical schoolsmeetingsmemberneuroprotectionnovelnovel therapeutic interventionnovel therapeuticsoptic nerve regenerationposterspre-clinicalregenerative approachretinal ganglion cell regenerationsight restorationsocialsymposiumunpublished worksweb site
项目摘要
Project Summary
The present application requests funds to support travel for young scientists to attend the XV Biennial Meeting
of the Association for Ocular Pharmacology and Therapeutics (AOPT) in Miami from March 4th-7th, 2021. This
is a conference that brings together scientists who are developing new ways to treat eye diseases. AOPT is a
global not-for-profit 501(c)3 organization for scientists and individuals from all disciplines related to ocular
pharmacology and its therapeutic applications to eye disease. AOPT has a diverse, multi-national membership
composed of preclinical and clinical scientists, students, and healthcare professionals. Members are from
academic institutions, pharma and biotech industries, device companies, clinics and private practice. To
achieve its mission, the society organizes biennial conferences and provides editorial leadership for the peer-
reviewed Journal of Ocular Pharmacology and Therapeutics. The mission of AOPT is threefold (from AOPT
website: www.aopt.org): (1) To serve as a global forum and network for the publication, dissemination and
exchange of information and knowledge on treatments of eye diseases, from basic and clinical ocular
pharmacology and therapeutics to related disciplines such as pharmacokinetics and dynamics, metabolism,
translational research, safety, drug delivery, and pharmaceutics; (2)To promote the advancement of research
and scientific progress in these fields; (3) To assist researchers and eye-care professionals in furthering their
understanding of the treatment of ocular disorders. In line with the AOPT mission, the specific Aims of the R13
application is: (I) To enhance the emerging careers of 20 young scientists (including women and
underrepresented minorities) in ocular therapeutics by providing travel awards; (II) To provide a forum for
dissemination of the most recent advances in the state of knowledge on novel therapeutic approaches to
ocular disorders and disease; (III) To create an environment that will facilitate the exchange of novel ideas
among basic and clinician scientists and generate the opportunity for vision scientists of all ethnic groups and
social backgrounds to meet and establish research collaborations. The theme of AOPT-2021 is “Restoring
vision through Regeneration” and a number of sessions are scheduled which are focused on regenerative
medicine related to anterior as well as posterior eye segments.
项目概要
本申请请求资金支持年轻科学家参加第十五届双年度会议的旅费
眼部药理学和治疗协会 (AOPT) 将于 2021 年 3 月 4 日至 7 日在迈阿密举行会议。
是一个汇聚了正在开发治疗眼部疾病新方法的科学家的会议。
全球非营利 501(c)3 组织,由与眼科相关的所有学科的科学家和个人组成
AOPT 的药理学及其在眼病治疗中的应用拥有多元化的跨国成员。
成员由临床前和临床科学家、学生和医疗保健专业人员组成。
学术机构、制药和生物技术行业、设备公司、诊所和私人诊所。
为了实现其使命,学会每两年组织一次会议,并为同行提供编辑领导
评论《眼部药理学和治疗学杂志》。AOPT 的使命有三重(摘自 AOPT)。
网站:www.aopt.org):(1)作为出版、传播和
交流有关眼科疾病治疗的信息和知识,包括基础和临床眼科
药理学和治疗学相关学科,如药代动力学和动力学、代谢、
(二)促进研究进步
以及这些领域的科学进展;(3) 协助研究人员和眼保健专业人员进一步发展他们的研究成果;
对眼部疾病治疗的理解 与 AOPT 使命一致,R13 的具体目标。
申请是:(一)促进20名青年科学家(包括女性和女性)的新兴职业生涯
(二)提供论坛
传播有关新型治疗方法的最新知识进展
眼部疾病和疾病; (III) 创造一个有利于新思想交流的环境
基础科学家和临床科学家之间的交流,为各族裔的视觉科学家创造机会,
AOPT-2021 的主题是“恢复”。
通过再生实现愿景”,并安排了一些重点关注再生的会议
与前眼段和后眼段相关的医学。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sanjoy K Bhattacharya其他文献
Sanjoy K Bhattacharya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sanjoy K Bhattacharya', 18)}}的其他基金
XV Association for Ocular Pharmacology and Therapeutics Meeting (AOPT 2021)
第十五届眼部药理学和治疗协会会议(AOPT 2021)
- 批准号:
10308550 - 财政年份:2020
- 资助金额:
$ 2.9万 - 项目类别:
Novel Targets to Promote RGC Axon Regeneration: Insights from Unique RGC Cohorts
促进 RGC 轴突再生的新目标:来自独特 RGC 队列的见解
- 批准号:
9340195 - 财政年份:2016
- 资助金额:
$ 2.9万 - 项目类别:
相似国自然基金
HTRA1介导CTRP5调控脂代谢通路在年龄相关性黄斑变性中的致病机制研究
- 批准号:82301231
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PLAAT3降低介导线粒体降解异常在年龄相关性白内障发病中的作用及机制
- 批准号:82301190
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
跨尺度年龄自适应儿童头部模型构建与弥漫性轴索损伤行为及表征研究
- 批准号:52375281
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
ALKBH5通过SHP-1调控视网膜色素上皮细胞铁死亡在年龄相关性黄斑变性中的作用机制研究
- 批准号:82301213
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
视网膜色素上皮细胞中NAD+水解酶SARM1调控自噬溶酶体途径参与年龄相关性黄斑变性的机制研究
- 批准号:82301214
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
XV Association for Ocular Pharmacology and Therapeutics Meeting (AOPT 2021)
第十五届眼部药理学和治疗协会会议(AOPT 2021)
- 批准号:
10308550 - 财政年份:2020
- 资助金额:
$ 2.9万 - 项目类别:
Characterization of purified myocilin: glaucoma as a protein misfolding disease
纯化肌纤蛋白的表征:青光眼作为一种蛋白质错误折叠疾病
- 批准号:
10723134 - 财政年份:2011
- 资助金额:
$ 2.9万 - 项目类别: